Your browser doesn't support javascript.
loading
In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes.
Schiavon, Michele; Visentin, Roberto; Giegerich, Clemens; Sieber, Jochen; Dalla Man, Chiara; Cobelli, Claudio; Klabunde, Thomas.
Affiliation
  • Schiavon M; Department of Information Engineering, University of Padova, Padova, Italy.
  • Visentin R; Department of Information Engineering, University of Padova, Padova, Italy.
  • Giegerich C; Translational Disease Modeling, R&D Digital and Data Sciences, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany.
  • Sieber J; Medical Affairs Diabetes Care EMEA, Becton, Dickinson and Company.
  • Dalla Man C; Department of Information Engineering, University of Padova, Padova, Italy.
  • Cobelli C; Department of Information Engineering, University of Padova, Padova, Italy.
  • Klabunde T; Translational Disease Modeling, R&D Digital and Data Sciences, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany.
Diabetes Technol Ther ; 22(8): 553-561, 2020 08.
Article in En | MEDLINE | ID: mdl-32125178

Full text: 1 Database: MEDLINE Main subject: Insulin, Long-Acting / Diabetes Mellitus, Type 1 / Insulin Glargine / Hypoglycemic Agents Type of study: Clinical_trials Limits: Humans Language: En Journal: Diabetes Technol Ther Journal subject: ENDOCRINOLOGIA / TERAPEUTICA Year: 2020 Type: Article Affiliation country: Italy

Full text: 1 Database: MEDLINE Main subject: Insulin, Long-Acting / Diabetes Mellitus, Type 1 / Insulin Glargine / Hypoglycemic Agents Type of study: Clinical_trials Limits: Humans Language: En Journal: Diabetes Technol Ther Journal subject: ENDOCRINOLOGIA / TERAPEUTICA Year: 2020 Type: Article Affiliation country: Italy